Download presentation
Presentation is loading. Please wait.
Published byUrsula Charles Modified over 8 years ago
1
Five Years of Flu Seasons: A Study of Trends and Lessons Learned in Maryland Tiffany Tate, MHS Maryland Partnership for Prevention, Inc. National Immunization Conference March 8, 2006
2
Acknowledgements Maryland’s Local Health Departments Greg Reed, MPA, Maryland DHMH JR Ransom, MPH, NACCHO Journal of Public Health Management and Practice
3
Maryland Partnership for Prevention, Inc. Maryland’s adult immunization coalition and parent to childhood immunization coalition 501(c)3 since 1999 Holds grant agreement with Maryland DHMH to complete Maryland Flu Season Final Report
4
About Maryland Population - 5,296,486 Ranks 19th in U.S. population Source: 2000 United States Census
5
Maryland Statistics 24 local health jurisdictions Participates with MMCAP 64.6% of Maryland residents over 65 years of age report having a flu shot in the past 12 months* LHDs administer appx. 10% of influenza vaccinations in state (Source: BRFSS, 2004)
6
Maryland Flu Season Final Report Data from series of surveys to LHDs Vaccine ordering practices Vaccine administration data Flu season experiences Plans for subsequent years Supply and delivery issues DHMH flu season activities Flu Season Wrap-Up Meeting
7
2001-2002 Flu Season “FDA Announces Delay in Release of Wyeth Flu Vaccine Lots”
8
Preparing for ’01-’02 Season LHDs ordered 113,350 doses of vaccine 33% LHDs placed initial vaccine order in April (Range: January – August) 58% ordered through MMCAP 16% ordered from more than one manufacturer/distributor
9
Impact of ‘01- ‘02 Delay Supplemental vaccine ordered* (33%) Avg price: $78 per vial Range: $57 to $125 per vial – up to 500% of MMCAP price Surplus vaccine (75%) Combined loss: $44,667 (16 LHDs) Postponed flu clinics (66%) *50% needed additional vaccine but some were prohibited from ordering
10
Impact of 2001-2002 Delay (cont.) Delayed advertisement of flu clinics (58%) Loaned vaccine to others (41%) Reduced number of clinics (37%) Prioritized according to MD Flu Plan (37%) Cancelled clinics (25%) Ran out of vaccine during clinic (20%)
11
Overview ’01-’02 Flu Season 89,959 vaccinations administered by LHDs 63% of LHDs administered more vaccinations than in previous years 75% of LHDs reported a surplus of vaccine
12
’01-’02 Lessons Learned Order vaccine early Order from a “reliable” source Order from >1 manufacturer Announce flu clinics after vaccine received Supplemental vaccine can result in surplus Stay informed
13
2002-2003 Flu Season “CDC: No Flu Vaccine Supply or Delivery Issues Anticipated”
14
Preparing for ’02-’03 Season LHDs ordered 101,750* doses of vaccine 56% LHDs ordered vaccine in March (up from April previous year) 66% ordered through MMCAP (up from 58%) 39% ordered from more than one manufacturer/distributor (up from 16%) *23 of 24 LHDs reporting
15
Overview ’02-’03 Season Appx. 95,000 doses of vaccine administered 50% LHDs administered more vaccinations than in previous years No LHDs needed supplemental vaccine (v. 50% previous year)
16
’02-’03 Lessons Learned No Delays or Shortages =
17
2003-2004 Flu Season “CDC: No Flu Vaccine Supply or Delivery Issues Anticipated” Summer 2003
18
Preparing for ’03-’04 Season LHDs ordered 100,350 doses of injectable vaccine 41% LHDs ordered more vaccine than in previous years >50% ordered from more than one manufacturer/distributor (up from 39%) 58% ordered from MMCAP
19
2003-2004 Flu Season Update “CDC: Flu Activity Peaks Early” Fall 2003
20
Response to Early Peak November ’03 Highly-publicized child deaths from flu LHDs report increased vaccine demand and shortages DHMH institutes weekly conference calls December ‘03 Maryland Governor and Secretary of Health independently negotiate agreement with MedImmune
21
Response to Early Peak December ‘03 Mid: LHDs receive 8,100 doses of FluMist ordered through DHMH Late: Maryland receives and distributes 1,700 doses of injectable vaccine from CDC January ’04 Early: 2,110 doses of Chiron product shipped to LHDs
22
LHDs’ Response Waiting lists compiled (62%) Referred patients to private providers (56%) Referred patients to commercial vaccinators (50%) Loaned vaccine to others (18%)
23
Impact of Early Peak on LHDs Ordered supplemental vaccine due to early peak (90%) Ran out of vaccine during early peak (68%) Had surplus after ordering supplemental vaccine (68%)
24
Overview ’03-’04 Season LHDs administered 104,909 doses of injectable and intranasal vaccine 68% administered more vaccinations than in previous seasons
25
’03-’04 Lessons Learned Timely communication is important Commercial vaccinators can be a resource in times of crisis Media influential in public’s response to vaccine shortages High level partnerships are essential during shortages and delays
26
’03-’04 Lessons Learned (cont.) Supplemental vaccine orders can result in increased surplus Few are interested in late-season vaccinations
27
2004-2005 Flu Season “CDC: No Flu Vaccine Supply or Delivery Issues Anticipated” Summer 2004
28
Preparing for ’04-’05 Season LHDs ordered 134,820 doses of injectable and intranasal vaccine 54% LHDs ordered more vaccine than in previous years 60% ordered from more than one manufacturer/distributor 50% ordered from MMCAP
29
2004-2005 Flu Season Update “Chiron Experiences Manufacturing Problems” October 5, 2004
30
Response to Shortage Only 50% of anticipated vaccine supply available DHMH takes control of and redistributes 50,000 doses of vaccine already delivered to LHDs CDC nationalizes vaccine & designates priority groups MMCAP contract for public health was honored
31
LHDs’ Response to Shortage Loaned to LTCFs (70%) Referred patients to commercial vaccinators (58%) Referred to private providers (41%) Borrowed vaccine (25%) Compiled waiting lists (25%)
32
Impact of Shortage on LHDs Postponed or cancelled clinics (70%) Ordered supplemental vaccine (62%) Loaned vaccine to other agencies (66%) Ran out of vaccine in during clinic (4%)
33
Impact of Shortage (cont) Surplus of vaccine 33% of LHDs quantified loss from excess injectable - $22,000 (Range: $582 to $9,134) 50% of LHDs quantified loss from excess intranasal - $50,000 (Range: $64 to $15,840)
34
Overview ’04-’05 Season LHDs administered 109,173 doses of injectable and intranasal vaccine 70% administered more vaccinations than in previous seasons 58% of LHDs had excess injectable vaccine 63% had excess intranasal vaccine
35
’04-’05 Lessons Learned Order from more than one manufacturer Public not yet receptive to intranasal vaccine Maryland responds well to flu crises Use recorded messages Timely communication is critical Delay scheduling clinics until vaccine is in hand
36
’04-’05 Lessons Learned (cont.) Improved expertise in mass clinics needed Standard phone systems cannot handle surge in calls Don’t use waiting lists MMCAP contracts are consistently honored Supplemental orders result in increased surplus Few interested in late-season vaccinations
37
2005-2006 Flu Season “CDC: No Flu Vaccine Supply or Delivery Issues Anticipated” Summer 2005
38
Preparing for ’05-’06 Season LHDs ordered 142,840 doses of injectable and intranasal vaccine 66% ordered from more than one manufacturer/distributor >60% ordered more vaccine than in previous years 62% ordered from MMCAP
39
2005-2006 Flu Season Update “Chiron Lots Delayed— To Produce About Half of Planned Estimates” October 2005
40
‘05-’06Lessons Learned Order from more than one manufacturer Order from MMCAP – some distributors’ redistribution illogical Commercial vaccinators can be a resource during shortages and delays Communication between all stakeholders is important
41
Recurring Themes: 2001-2005 Maryland Flu Seasons Order from more than one manufacturer Order vaccine early/pre-book Partner with other providers to ensure vaccinations to vulnerable populations Delay scheduling/announcement of clinics until vaccine in hand
42
Recurring Themes: 2001-2005 Maryland Flu Seasons MMCAP is a reliable mechanism for securing vaccine, even during challenged seasons Supplemental vaccine orders often result in increased surplus Increased education on effectiveness of late-season vaccination needed
43
Flu Vaccine Ordered v. Administered ( Maryland 2001 – 2005)
44
LHDs Ordering from MMCAP (Maryland 2001 – 2005)
45
LHDs Ordering from >1 Manufacturer/Distributor (Maryland 2001 – 2005)
46
Conclusions Despite supply and delivery challenges: LHDs became more savvy in ordering flu vaccine LHDs administer more flu vaccinations than in previous years Communications and partnerships improve each year
48
Contact Information Tiffany Tate Maryland Partnership for Prevention P.O. Box 702 Owings Mills, MD 21117 410-902-4677 mdpartnershipforprevention@msn.com
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.